SCHEMBL11623959

SCHEMBL11623959

N=C1SCCN1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1952345 0.72 — —
SCHEMBL22692592 0.63 — —
SCHEMBL21859351 0.63 — —
SCHEMBL21859417 0.60 INMT (0.56) —
SCHEMBL21859352 0.59 — —
SCHEMBL24044988 0.58 — —
SCHEMBL21676093 0.50 — —
SCHEMBL11755346 0.47 INMT (0.39) —
Hydrazine SCHEMBL23924898 0.42 — —
Hydrazine SCHEMBL3236675 0.41 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4091105-A 2-Imino-3-aminothiazolidines and indoleamine-N-methyltransferase inhibition MERCK & CO., INC. (US) 1978-05-23 — — US disclosed
US-4091105-A 2-Imino-3-aminothiazolidines and indoleamine-N-methyltransferase inhibition MERCK & CO., INC. (US) 1978-05-23 — — US disclosed
US-4091105-A 2-Imino-3-aminothiazolidines and indoleamine-N-methyltransferase inhibition MERCK & CO., INC. (US) 1978-05-23 — — US disclosed
Send feedback